Table 3.

Hazard of waitlisting before and after 2014 Kidney Allocation System policies among patients with first onset of kidney failure (2005–2017) by sex

ModelsWomen (versus Men) Hazard Ratio (95% Confidence Interval)
Access to WaitlistingBefore 2014 Kidney Allocation SystemAfter 2014 Kidney Allocation System
 Unadjusted model0.79 (0.78 to 0.80)0.83 (0.82 to 0.85)
 Minimally adjusted modela (Model 1)0.86 (0.85 to 0.87)0.90 (0.89 to 0.92)
 Fully adjusted modelb (Model 2)0.89 (0.88 to 0.89)0.94 (0.92 to 0.96)
Fully adjusted model (Model 2) stratified by cause of kidney failure
 Type 2 diabetes0.72 (0.71 to 0.73)0.77 (0.74 to 0.79)
 Type 1 diabetes0.96 (0.93 to 0.99)1.03 (0.96 to 1.11)
 Hypertension0.90 (0.88 to 0.92)0.94 (0.90 to 0.98)
 Cystic disease1.04 (1.00 to 1.07)1.18 (1.11 to 1.25)
 GN0.95 (0.93 to 0.97)0.98 (0.94 to 1.02)
 Other1.13 (1.11 to 1.16)1.18 (1.11 to 1.24)
  • a Adjusted for attributed cause of kidney failure, age, race/ethnicity, and body mass index (BMI).

  • b Adjusted for attributed cause of kidney failure, age, race/ethnicity, BMI, yr of first kidney failure treatment, median zip code household income, insurance coverage, Organ Procurement and Transplant Network region, smoking, chronic obstructive pulmonary disease, cancer, coronary artery disease, congestive heart failure, stroke or transient ischemic attack, peripheral vascular disease.